Company record
CD Bioparticles manufactures liposome, synthetic polymer and biopolymer reagents and offers an extensive catalog of associated products. The portfolio includes nanoparticles, a range of lipids, chelating agents, cleavable linkers, bioactive matrices and other organic materials. Available liposome formats encompass metal‑organic frameworks (MOFs), magnetic, reactive, fluorescent and drug‑loaded variants. Additional offerings comprise sterols, adjuvants, lipidomics reagents, phospholipids, sphingolipids and related compounds. The company also supplies hydrogels, inhibitors, initiators, catalysts, ligands and further nanoparticle types. Beyond product sales, CD Bioparticles provides services such as drug‑targeting strategy development, nanoparticle formulation, bioparticle analysis, drug testing and lipid development. Its solutions are applicable to medical devices, cancer therapies, diagnostic assays, and the treatment of neurological and cardiovascular diseases. The primary customer base includes biotech firms, university laboratories, research institutes and pharmaceutical manufacturers.
This directory record does not yet have a linked material-flow brief.